Roche Holding AG

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • 454 Life Sciences;AAdheron Therapeutics;Amira Medical;Anadys Pharmaceuticals;ARIUS Research;Bina Technologies;BioImagene;BioVeris;Boehringer Mannheim;Carmot Therapeutics;Chugai Pharmaceutical;CompuChem;Disetronic;Dutalys;Enterprise Therapeutics;F. Hoffmann-La Roche;Foundation Medicine;ForSight VISION4;GenMark Diagnostics;Genentech;Genia Technologies;GlycArt Biotechnology;Good Therapeutics;Hoffmann-La Roche;Ignyta;Inception 5’ Inflazome;Igen International;Innovatis;InterMune;Jecure Therapeutics;Marcadia Biotech;Medingo;Memory Pharmaceuticals;Mirus Bio;mtm laboratories;National Health Laboratories;NimbleGen Systems;Piramed;Promedior;PVT Probenverteiltechnik;Roche Diagnostics;Roche Innovation Center Copenhagen (formerly Santaris Pharma);Seragon Pharmaceuticals;Spark Therapeutics;Stratos Genomics;Syntex;Tensha Therapeutics;Therapeutic Human Polyclonals;Trophos;Tusk Therapeutics;Ventana Medical Systems
See more in Biomedtracker

Latest on Roche Holding AG